Latest filing published 28 Jul 2025 for Verve Therapeutics, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Joan Nickerson in Verve Therapeutics, Inc. Over a trading history stretching from 1 April 2024 to 25 July 2025, the count stands at 3 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 28 July 2025: a transaction, in Verve Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations